Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Vickers

Showing results (571-580 of 665) with videos related to

Pageof 67
Sort By:
Journal of the National Cancer Institute|December 6, 2012
Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populationsChristopher A Haiman, Daniel O Stram, Andrew J Vickers, et al.
CA: a Cancer Journal for Clinicians|November 16, 2010
Sixty years of CA: a cancer journal for cliniciansTed Gansler, Patricia A Ganz, Marcia Grant, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Incorporating Multiple Perspectives Into the Development of an Electronic Survivorship Platform for Head and Neck CancerTalya Salz, Rebecca B Schnall, Mary S McCabe, et al.
Molecular & Cellular Proteomics : MCP|July 25, 2014
Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancerArpi Nazarian, Kevin Lawlor, San San Yi, et al.
European Urology|December 25, 2018
Guidelines for Reporting of Statistics for Clinical Research in UrologyMelissa Assel, Daniel Sjoberg, Andrew Elders, et al.
Transfusion|April 11, 2012
The role of comparative effectiveness research in transfusion medicine clinical trials: proceedings of a National Heart, Lung, and Blood Institute workshopMorris A Blajchman, Jeffrey L Carson, John W Eikelboom, et al.
Cancer|November 1, 2021
Have urinary function outcomes after radical prostatectomy improved over the past decade?Matthew B Clements, Caroline C Gmelich, Emily A Vertosick, et al.
Nature Communications|December 31, 2025
EatA mediated degradation of intestinal mucus is species-specific and driven by MUC2 structural featuresSergio Trillo-Muyo, Brendan Dolan, Frida Svensson, et al.
Infection and Immunity|November 22, 2021
Enterotoxigenic <i>Escherichia coli</i> Degrades the Host MUC2 Mucin Barrier To Facilitate Critical Pathogen-Enterocyte Interactions in Human Small IntestineAlaullah Sheikh, Tamding Wangdi, Tim J Vickers, et al.
Clinical Genitourinary Cancer|September 11, 2024
Quantification of Gleason Pattern 4 Metrics Identifies Pathologic Progression in Patients With Grade Group 2 Prostate Cancer on Active SurveillanceMarlon Perera, Melissa Assel, Sunny Nalavenkata, et al.
Pageof 67

Showing results (571-580 of 665) with videos related to

Sort By:
Pageof 67
Journal of the National Cancer Institute|December 6, 2012
Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populationsChristopher A Haiman, Daniel O Stram, Andrew J Vickers, et al.
CA: a Cancer Journal for Clinicians|November 16, 2010
Sixty years of CA: a cancer journal for cliniciansTed Gansler, Patricia A Ganz, Marcia Grant, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Incorporating Multiple Perspectives Into the Development of an Electronic Survivorship Platform for Head and Neck CancerTalya Salz, Rebecca B Schnall, Mary S McCabe, et al.
Molecular & Cellular Proteomics : MCP|July 25, 2014
Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancerArpi Nazarian, Kevin Lawlor, San San Yi, et al.
European Urology|December 25, 2018
Guidelines for Reporting of Statistics for Clinical Research in UrologyMelissa Assel, Daniel Sjoberg, Andrew Elders, et al.
Transfusion|April 11, 2012
The role of comparative effectiveness research in transfusion medicine clinical trials: proceedings of a National Heart, Lung, and Blood Institute workshopMorris A Blajchman, Jeffrey L Carson, John W Eikelboom, et al.
Cancer|November 1, 2021
Have urinary function outcomes after radical prostatectomy improved over the past decade?Matthew B Clements, Caroline C Gmelich, Emily A Vertosick, et al.
Nature Communications|December 31, 2025
EatA mediated degradation of intestinal mucus is species-specific and driven by MUC2 structural featuresSergio Trillo-Muyo, Brendan Dolan, Frida Svensson, et al.
Infection and Immunity|November 22, 2021
Enterotoxigenic <i>Escherichia coli</i> Degrades the Host MUC2 Mucin Barrier To Facilitate Critical Pathogen-Enterocyte Interactions in Human Small IntestineAlaullah Sheikh, Tamding Wangdi, Tim J Vickers, et al.
Clinical Genitourinary Cancer|September 11, 2024
Quantification of Gleason Pattern 4 Metrics Identifies Pathologic Progression in Patients With Grade Group 2 Prostate Cancer on Active SurveillanceMarlon Perera, Melissa Assel, Sunny Nalavenkata, et al.
Pageof 67